What is the appropriate diagnostic and therapeutic approach for a 60‑year‑old woman with two‑week generalized weakness after a febrile respiratory illness, who has normal vital signs, mild anemia, borderline thrombocytopenia, eosinophilia, low‑normal vitamin B12, normal iron studies, normal thyroid function, modestly elevated erythrocyte sedimentation rate, low‑grade Widal titers, and low‑normal calcium and albumin?

Diagnostic and Therapeutic Approach

This patient requires immediate vitamin B12 supplementation (1000 mcg intramuscular daily for 1-2 weeks) given her low-normal B12 level (151 pg/mL) which can explain her generalized weakness, borderline thrombocytopenia (108 K/µL), and mild anemia, particularly after a recent febrile illness that may have unmasked this deficiency 1, 2.

Immediate Management Priority

The constellation of findings—generalized weakness, borderline thrombocytopenia, mild anemia with normal MCV, and vitamin B12 at 151 pg/mL (reference range typically 180-914 ng/L)—strongly suggests early vitamin B12 deficiency as the primary driver of her symptoms. While her MCV is normal (88.1 fL), this does not exclude B12 deficiency; macrocytosis may be absent in early deficiency or masked by concurrent conditions 1, 3.

Why B12 Deficiency is the Key Issue:

• Thrombocytopenia (108 K/µL) with B12 of 151: This combination is well-documented, with isolated thrombocytopenia occurring even without classic megaloblastic features 1
• Post-viral weakness: The recent febrile respiratory illness likely increased metabolic demands, unmasking subclinical B12 deficiency 2, 4
• Rapid reversibility: B12 replacement typically resolves hematologic abnormalities within 1-4 weeks 1, 2, 4

Specific Diagnostic Steps

1. Confirm B12 Deficiency Etiology

• Check anti-intrinsic factor antibodies and anti-parietal cell antibodies to diagnose pernicious anemia 2
• Review peripheral blood smear for hypersegmented neutrophils (>5 lobes), which may be present even with normal MCV 4, 3
• Measure methylmalonic acid and homocysteine if B12 deficiency diagnosis is uncertain (both elevated in true deficiency)

2. Evaluate the Eosinophilia (14%, AEC 0.58)

The eosinophilia requires attention but is likely secondary:

• Stool examination for ova and parasites (3 samples) to exclude helminthic infections, particularly given the Widal titers
• Consider IgE levels and chest imaging if pulmonary eosinophilia suspected
• The eosinophilia may resolve with B12 treatment if reactive to the underlying deficiency

3. Address the Widal Test Results (O 1:160, H 1:320)

These titers are low-grade and non-diagnostic for acute typhoid fever:

• In endemic areas, background titers are common
• Her normal temperature (36.5°C), resolved fever, and stable vitals argue against active enteric fever
• If typhoid is genuinely suspected: blood culture (gold standard), Typhidot IgM, or PCR testing
• Do not treat empirically based on these titers alone

4. Investigate Post-Viral Syndrome

• The 15-day fever with dry cough warrants consideration of:
  • COVID-19 testing (if not done) or serology for recent infection
  • Chest X-ray to exclude residual pneumonitis
  • Post-viral fatigue syndrome is common but remains a diagnosis of exclusion

Treatment Algorithm

Immediate (Week 1-2):

1. Vitamin B12 (cyanocobalamin or hydroxocobalamin) 1000 mcg intramuscular daily for 7-14 days 1, 2, 5

   • This intensive regimen rapidly replenishes stores
   • Expect reticulocytosis within 3-5 days, platelet recovery within 1-2 weeks 1, 2

2. Monitor complete blood count weekly to document hematologic response

   • Hemoglobin should rise by 1-2 g/dL within 2 weeks
   • Platelet count should normalize within 2 weeks 1

Maintenance (After Initial Loading):

• Vitamin B12 1000 mcg intramuscular monthly for life if pernicious anemia confirmed 2
• Oral B12 (1000-2000 mcg daily) is an alternative if absorption is intact, but IM is preferred initially given the thrombocytopenia

Concurrent Supportive Care:

• No iron supplementation needed: Iron studies are normal (iron 66.30, TIBC 265, saturation ~25%)
• Vitamin D is adequate (38.46 ng/mL)
• Thyroid function is normal

Critical Pitfalls to Avoid

1. Do not dismiss low-normal B12 (151 pg/mL) as insignificant: Levels <200 pg/mL are associated with clinical deficiency, and hematologic manifestations can occur without macrocytosis 1, 6, 3

2. Do not treat based on Widal titers alone: These are non-specific in endemic areas and do not correlate with her current clinical picture (afebrile, stable)

3. Do not delay B12 treatment waiting for confirmatory tests: Start replacement immediately; anti-intrinsic factor antibodies can be checked concurrently 2

4. Do not overlook autoimmune clustering: B12 deficiency (pernicious anemia) can coexist with other autoimmune conditions; her normal thyroid function now doesn't exclude future autoimmune thyroid disease 2, 4

5. Do not misinterpret thrombocytopenia as ITP or other primary disorder: B12 deficiency can present with isolated thrombocytopenia mimicking immune thrombocytopenia 1

Expected Outcomes

With appropriate B12 replacement:

• Subjective improvement in weakness within 1 week
• Platelet count normalization within 2 weeks 1
• Hemoglobin improvement to >12 g/dL within 4-8 weeks 2
• Complete hematologic recovery expected given the mild degree of cytopenias 1, 2, 3

Follow-Up Plan

• Week 2: Recheck CBC, reticulocyte count (should be elevated)
• Week 4: Recheck CBC, B12 level (should be >300 pg/mL)
• Month 3: Confirm hematologic normalization, establish maintenance B12 schedule
• Ongoing: Annual CBC and B12 monitoring if on maintenance therapy

The eosinophilia and Widal titers should be reassessed after B12 repletion; if persistent, pursue dedicated parasitology evaluation and consider infectious disease consultation.